Skip to content

SiliconANGLE

the latest

AI

COVID-19 might be bitter medicine for what ails AI investing

Is investor belt-tightening brought on by COVID-19 the bitter medicine needed to bring sanity to the artificial intelligence funding bubble, flush out fakes, and shift venture capitalists’ attention to the most deserving companies? In 2019, private…

Send us a news tip

Send us a News Tip

  • This field is for validation purposes and should be left unchanged.
  • Max. file size: 244 MB.

Sign in

SIGN IN

Bio

Ethics statement

Extract the signal from the noise

Get SiliconANGLE updates and analysis.

Contact us

Partner with us

Contact us

Guest inquiry